At Lykos Therapeutics, our mission is to transform the way mental health is treated. We aspire to challenge the status quo through the development of novel therapies and therapeutic approaches to treat mental health conditions. With 30+ years of experience researching psychedelic-assisted therapies, we remain focused on following rigorous science from which we can develop and commercialize novel treatment options. 

Founded in 2014 by the non-profit Multidisciplinary Association for Psychedelic Studies (“MAPS”), we are a for-profit public benefit corporation (“PBC”). As a PBC, we consider the impact of our decisions on society just as we think about financial implications. Everything we do is looked at through a public benefit lens. To learn more, visit us at www.lykospbc.com. 

Life Sciences

Therapeutics

Lykos Therapeutics (formerly MAPS PBC)

Lykos Therapeutics (formerly MAPS PBC)'s headquarters in San Jose, United States

Michael Mullette

Andrew Septimus

Kacy Hutchison

Michelle Lacy

Blair Clark - Schoeb

Berra Yazar - Klosinski

Kristin Rand

Jessica R. Riggleman

Amy Laverdiere

James Acer

John Kim

Gretchen Shaub

Melissa Clinton

Description

People (18)

Michael Mullette

Brooke Balliett

Reba Hsu

Sarah Murray

Danielle Herrera

Tara Samiy

Ari Kellner

Jessica R. Riggleman

Wael Garas

Andrew Septimus

Desra Diehl

Judy Calkins

Kacy Hutchison

Michelle Lacy

Melissa Clinton

Gretchen Shaub

Amy Laverdiere

Joshua Mazanetz

Jobs